Showing results (381-390 of 485) with videos related to

Sort By:
Pageof 49
Liver International : Official Journal of the International Association for the Study of the Liver|March 28, 2026
The Conjugated Bile Acids Profile Suggests a Novel Liver-Muscle Axis Associated With Sarcopenia in Chronic Liver DiseaseMotoh Iwasa, Akiko Eguchi, Motoyuki Kohjima, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2013
Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammationHiroshi Kitamura, Shunsuke Kimura, Yoshinori Shimamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Effective treatment of metastatic rhabdomyosarcoma with pazopanib]Akari Hashimoto, Kohichi Takada, Rishu Takimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2026
Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94)Takeshi Sasaki, Atsushi Igarashi, Shin Ebara, et al.
Pancreas|June 29, 2006
Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitisMasanori Asada, Akiyoshi Nishio, Kazushige Uchida, et al.
BMC Nephrology|March 13, 2012
Predicting the outcome of chronic kidney disease by the estimated nephron number: the rationale and design of PRONEP, a prospective, multicenter, observational cohort studyToshiyuki Imasawa, Takashi Nakazato, Hiroo Ikehira, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 3, 2005
Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitisShinya Ohashi, Akiyoshi Nishio, Hajime Nakamura, et al.
Anticancer Research|November 1, 2023
Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary SiteNaotaka Nishiyama, Yuki Kita, Katsuhiro Ito, et al.
Cancer Science|August 23, 2022
Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time biasHikari Otsuka, Yuki Kita, Katsuhiro Ito, et al.
International Journal of Clinical Oncology|June 29, 2023
Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022Satoru Muto, Takeshi Matsubara, Takamitsu Inoue, et al.
Pageof 49